Suzuki Hidekazu, Hirashima Tomonori, Kobayashi Masashi, Sasada Shinji, Okamoto Norio, Morishita Naoko, Tamiya Motohiro, Matsui Kaoru, Kusunoki Yoko, Kawase Ichiro
Dept. of Thoracic Malignancy, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases.
Gan To Kagaku Ryoho. 2010 Mar;37(3):543-6.
A 66-year-old woman with small-cell lung cancer was administered chemo-radiotherapy consisting of cisplatin (CDDP) and etoposide (ETP). From day 3, she developed vomiting and hyponatremia that persisted despite fluid infusion and cortico-steroid administration. On day 7, the hyponatremia worsened (serum sodium level, 109 mEq/L), leading to disturbed consciousness and convulsions. The serum sodium level gradually increased after intravenous administration of hypertonic saline; on day 22, the serum sodium level was almost normal without any neurological implication. We diagnosed this clinical condition as renal salt-wasting syndrome (RSWS) on the basis of dehydration and high urinary sodium excretion at the onset. In the second course of chemotherapy, CDDP was replaced with carboplatin (CBDCA); consequently, hyponatremia was not observed. Hyponatremia that develops after the administration of CDDP may be due to not only the syndrome of inappropriate secretion of anti diuretic hormone (SIADH) but also RSWS. When RSWS is suspected, hypertonic saline should be administered.
一名66岁的小细胞肺癌女性接受了由顺铂(CDDP)和依托泊苷(ETP)组成的放化疗。从第3天起,她出现呕吐和低钠血症,尽管进行了补液和给予皮质类固醇治疗,但症状仍持续存在。在第7天,低钠血症加重(血清钠水平为109 mEq/L),导致意识障碍和惊厥。静脉输注高渗盐水后,血清钠水平逐渐升高;在第22天,血清钠水平几乎恢复正常,且无任何神经方面的问题。根据发病时的脱水和高尿钠排泄情况,我们将这种临床情况诊断为肾性失盐综合征(RSWS)。在第二个化疗疗程中,用卡铂(CBDCA)替代了顺铂(CDDP);结果,未观察到低钠血症。顺铂给药后出现的低钠血症可能不仅归因于抗利尿激素分泌不当综合征(SIADH),还可能是肾性失盐综合征(RSWS)。当怀疑是肾性失盐综合征(RSWS)时,应给予高渗盐水。